Infectious vaginitis, cervicitis, and pelvic inflammatory disease

S Shroff - Medical Clinics, 2023 - medical.theclinics.com
Vaginal symptoms are one of the most common reasons women consult with physicians and
can significantly impact quality of life. 1, 2 Differential diagnosis of vaginal discharge …

[HTML][HTML] European cancer mortality predictions for the year 2022 with focus on ovarian cancer

M Dalmartello, C La Vecchia, P Bertuccio, P Boffetta… - Annals of …, 2022 - Elsevier
Background Cancer mortality rates, though not absolute numbers of deaths, have been
decreasing over the last three decades in Europe. Materials and methods We estimated …

Lymphatic vasculature in ovarian cancer

S Pal, S Bhowmick, A Sharma… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Ovarian cancer (OVCA) is the second most common gynecological cancer and one of the
leading causes of cancer related mortality among women. Recent studies suggest that …

Ovarian, uterine, and vulvovaginal cancers: screening, treatment overview, and prognosis

DG Kwolek, S Gerstberger, S Tait, JM Qiu - Medical Clinics, 2023 - medical.theclinics.com
Gynecologic cancers, uterine, ovarian, and vulvovaginal, affect approximately 96,000
women and result in approximately 29,000 deaths in the United States annually. In 2022, it …

Recent advancements of antiangiogenic combination therapies in ovarian cancer

D An, S Banerjee, JM Lee - Cancer treatment reviews, 2021 - Elsevier
Ovarian cancer is a deadly malignancy with a growing therapeutic armamentarium, though
achieving sustained benefit in the clinic remains largely elusive. Through biomarker and …

[HTML][HTML] Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of …

VL Beesley, TL Ross, MT King, R Campbell… - Gynecologic …, 2022 - Elsevier
Objectives Knowledge on the course of symptoms patients with ovarian cancer experience
is limited. We documented the prevalence and trajectories of symptoms after first-line …

[HTML][HTML] Lipid regulatory proteins as potential therapeutic targets for ovarian cancer in obese women

J Yang, MS Stack - Cancers, 2020 - mdpi.com
Simple Summary Obesity is a recognized epidemic worldwide. Ovarian cancer (OvCa), the
most lethal gynecologic malignancy, is characterized by widely disseminated metastatic …

Impact of COVID-19 pandemic on ovarian cancer management: adjusting to the new normal

LS Jacome, SK Deshmukh… - Cancer Management …, 2021 - Taylor & Francis
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health …

[HTML][HTML] Drugs targeting tumor-initiating cells prolong survival in a post-surgery, post-chemotherapy ovarian cancer relapse model

BS Harrington, MK Ozaki, MW Caminear… - Cancers, 2020 - mdpi.com
Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In
terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors …

[HTML][HTML] What's in a name? Redefining type 2 diabetes remission

S Kalra, A Singal, T Lathia - Diabetes Therapy, 2021 - Springer
Diabetes remission is a concept that is marked by ample attention, but lack of unanimity.
This opinion piece explores existing definitions of diabetes remission and proposes a …